Brian Smith

发表

Relative bioavailability, food effect, and safety of the single-dose pharmacokinetics of omecamtiv mecarbil following administration of different modified-release formulations in healthy subjects

C. Banfield, F. Malik, M. L. Monsalvo, 2015, International journal of clinical pharmacology and therapeutics.

Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine

Edgar Bautista, T. Vu, A. van Hecken, 2018, Clinical pharmacology and therapeutics.

Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor

S. Lehto, D. Immke, K. Wild, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.

A. Shaywitz, M. Retter, E. Stein, 2012, Journal of the American College of Cardiology.

Pharmacokinetic and pharmacodynamic interactions between palifermin and heparin

William Smith, B. Olsson, Bing‐Bing Yang, 2015, Journal of clinical pharmacology.

Reduced TRPM8 expression underpins reduced migraine risk and attenuated cold pain sensation in humans

M. Backonja, N. Gavva, Brian Smith, 2019, Scientific Reports.

Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

L. Roskos, Bing‐Bing Yang, Brian Smith, 2010, Clinical pharmacokinetics.

EFFECTS OF AMG 145, A FULLY HUMAN MONOCLONAL ANTIBODY AGAINST PCSK9, ON LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN SUBJECTS TAKING STATINS: A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ASCENDING MULTIPLE-DOSE STUDY

A. Shaywitz, E. Stein, J. Gibbs, 2012 .

Pharmacokinetics of Irinotecan With and Without Panitumumab Coadministration in Patients With Metastatic Colorectal Cancer

H. Kennecke, J. Infante, Bing‐Bing Yang, 2013, Clinical pharmacology in drug development.

Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.

A. Shaywitz, M. Retter, E. Stein, 2012, Journal of the American College of Cardiology.